Association between glioma susceptibility and XRCC1 Arg399Gln polymorphism

October 28, 2013

DNA damage is an important mechanism of glioma. X-ray cross-complementing group 1 (XRCC1) is a DNA repair gene that participates in the base excision repair pathway. To date, many studies have been performed to investigate the association between the XRCC1 polymorphisms and risk of cancers such as breast cancer, and gastroesophageal cancer, but the number of studies that focused on glioma is relatively small. Evidence regarding the role of the single nucleotide polymorphisms in XRCC1 as genetic markers for glioma risk is inconsistent. Prof. Xinquan Gu and team from China-Japan Union Hospital of Jilin University, China performed a meta-analysis to identify statistical evidence for an association between the XRCC1 Arg399Gln, Arg194Trp, Arg280His polymorphisms and glioma risk by accumulating all published data. Meta-analysis results verified that the XRCC1 Arg399Gln polymorphism may be a biomarker of glioma susceptibility, especially in Asian populations. The Arg194Trp and Arg280His polymorphisms were found not to be associated with overall glioma risk. These findings, published in the Neural Regeneration Research (Vol. 8, No. 26, 2013), provide the necessary scientific basis for the glioma pathogenesis and glioma risk population screening.
-end-
Article: " Correlation between X-ray cross-complementing group 1 polymorphisms and the onset risk of glioma: a meta-analysis " by Xinquan Gu1, Hongyan Sun2, Liping Chang3, Ran Sun2, Hongfeng Yang4, Xuewen Zhang2, Xianling Cong2, 4 (1 Department of Urinary Surgery, China-Japan Union Hospital of Jilin University, Changchun 130033, Jilin Province, China; 2 Tissue Bank, China-Japan Union Hospital of Jilin University, Changchun 130033, Jilin Province, China; 3 Department of Cardiopathy, the Affiliated Hospital of Changchun University of Chinese Medicine, Changchun 130021, Jilin Province, China; 4 Department of Dermatology, China-Japan Union Hospital of Jilin University, Changchun 130033, Jilin Province, China)

Gu XQ, Sun HY, Chang LP, Sun R, Yang HF, Zhang XW, Cong XL. Correlation between X-ray cross-complementing group 1 polymorphisms and the onset risk of glioma: a meta-analysis. Neural Regen Res. 2013;8(26):2468-2477.

Contact:

Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
http://www.nrronline.org/

Full text:
http://www.sjzsyj.org/CN/article/downloadArticleFile.do?attachType=PDF&id=720

Neural Regeneration Research

Related Glioma Articles from Brightsurf:

Artificial intelligence enhances brain tumour diagnosis
A new machine learning approach classifies a common type of brain tumour into low or high grades with almost 98% accuracy, researchers report in the journal IEEE Access.

Mouse study shows how advancing glioma cells scramble brain function, blood flow
The first sign of trouble for a patient with a growing brain tumor is often a seizure.

New findings shed light on selective therapeutics for IDH1-mutated glioma
Findings of a new study led by Prof. XU Guowang from the Dalian Institute of Chemical Physics (DICP) of the Chinese Academy of Sciences and Prof.

Good news for NF patients with low grade glioma (LGG)
A paper published in the academic journal Neuro-Oncology by NF experts has demonstrated an increased understanding of low grade gliomas (LGG) occurring in children and adults with NF1.

Finding a cure for Fido's brain cancer may help us find a cure for ourselves
For cancers such as glioma, preclinical research models have failed to provide sufficient insight for medical progress.

Brain tumors remodel neuronal synapses to promote growth
Scientists discovered that glioma, a lethal form of brain cancer, alters the activity of neighboring neurons, accelerating a vicious cycle that drives tumor-associated epilepsy and tumor progression.

Study uncovers unexpected connection between gliomas, neurodegenerative diseases
New basic science and clinical research identifies TAU, the same protein studied in the development of Alzheimer's, as a biomarker for glioma development.

How do gliomas evolve?
The Glioma Longitudinal Analysis (GLASS) Consortium characterized diffuse glioma cells both before and after therapy to characterize how they change and why this form of malignant brain cancer is so difficult to treat.

New research published in cancer discovery identifies new drug target for glioblastoma
A new international study co-led by Cleveland Clinic has identified a new drug target for treating glioblastoma.

Synodos does it again: Breaking barriers to solve the 'impossible' problems
Treatment for low-grade gliomas in patients living with neurofibromatosis type 1 are now one step closer thanks to recent research discoveries initiated and funded by the Children's Tumor Foundation.

Read More: Glioma News and Glioma Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.